Track the Eastwood Bio-Medical Canada Inc. stock price and the full management transaction log of the company, a listed equity based in Canada. Shares trade on the CA market, under the authority of SEDI. Market capitalisation: €129.5m. The latest transaction was disclosed on 31 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Eastwood Bio-Medical Research Inc.. The full history is free.
105
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
39Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,806 of 29,062 companies
39.8
score / 100
Value
35
Quality
45
FCF yld0.0%
Earn yld-0.3%
EV/EBITDA·
ROE·
Gross mgn70%
Net mgn-43%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,000 shares@ CA$0.970.0014% mcap1.4% of flowCommon SharesTSXSEDI:4758371
Canonical exit: 29 Oct 2026 (T+90)
25 of 105 declarations
Acerca de Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. es una empresa centrada en el sector biomédico, que ofrece soluciones innovadoras para el mercado canadiense. Cotiza en la Bolsa de Valores de Toronto (XTSE).